Reinsurance Group of America Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $6.03 |
| EPS actual | $6.97 |
| EPS Surprise | 15.59% |
| Revenue estimate | 6.47B |
| Revenue actual | 6.494B |
| Revenue Surprise | 0.376% |
| Release date | Feb 05, 2026 |
| EPS estimate | $5.78 |
| EPS actual | $7.75 |
| EPS Surprise | 34.08% |
| Revenue estimate | 6.311B |
| Revenue actual | 6.635B |
| Revenue Surprise | 5.13% |
| Release date | Oct 30, 2025 |
| EPS estimate | $5.76 |
| EPS actual | $6.37 |
| EPS Surprise | 10.59% |
| Revenue estimate | 6.083B |
| Revenue actual | 6.229B |
| Revenue Surprise | 2.39% |
| Release date | Jul 31, 2025 |
| EPS estimate | $5.58 |
| EPS actual | $4.72 |
| EPS Surprise | -15.41% |
| Revenue estimate | 6.017B |
| Revenue actual | 5.614B |
| Revenue Surprise | -6.70% |
Last 4 Quarters for Reinsurance Group of America
Below you can see how RGA performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $192.45 |
| EPS estimate | $5.58 |
| EPS actual | $4.72 |
| EPS surprise | -15.41% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $196.55 |
| Jul 28, 2025 | $194.60 |
| Jul 29, 2025 | $193.79 |
| Jul 30, 2025 | $190.51 |
| Jul 31, 2025 | $192.45 |
| Aug 01, 2025 | $177.33 |
| Aug 04, 2025 | $177.10 |
| Aug 05, 2025 | $183.10 |
| Aug 06, 2025 | $183.69 |
| 4 days before | -2.09% |
| 4 days after | -4.55% |
| On release day | -7.86% |
| Change in period | -6.54% |
| Release date | Oct 30, 2025 |
| Price on release | $189.00 |
| EPS estimate | $5.76 |
| EPS actual | $6.37 |
| EPS surprise | 10.59% |
| Date | Price |
|---|---|
| Oct 24, 2025 | $189.42 |
| Oct 27, 2025 | $189.46 |
| Oct 28, 2025 | $186.85 |
| Oct 29, 2025 | $189.61 |
| Oct 30, 2025 | $189.00 |
| Oct 31, 2025 | $182.46 |
| Nov 03, 2025 | $181.54 |
| Nov 04, 2025 | $186.65 |
| Nov 05, 2025 | $187.38 |
| 4 days before | -0.222% |
| 4 days after | -0.86% |
| On release day | -3.46% |
| Change in period | -1.08% |
| Release date | Feb 05, 2026 |
| Price on release | $205.99 |
| EPS estimate | $5.78 |
| EPS actual | $7.75 |
| EPS surprise | 34.08% |
| Date | Price |
|---|---|
| Jan 30, 2026 | $202.75 |
| Feb 02, 2026 | $205.15 |
| Feb 03, 2026 | $202.53 |
| Feb 04, 2026 | $205.08 |
| Feb 05, 2026 | $205.99 |
| Feb 06, 2026 | $225.36 |
| Feb 09, 2026 | $219.32 |
| Feb 10, 2026 | $217.39 |
| Feb 11, 2026 | $220.70 |
| 4 days before | 1.60% |
| 4 days after | 7.14% |
| On release day | 9.40% |
| Change in period | 8.85% |
| Release date | May 07, 2026 |
| Price on release | $212.81 |
| EPS estimate | $6.03 |
| EPS actual | $6.97 |
| EPS surprise | 15.59% |
| Date | Price |
|---|---|
| May 01, 2026 | $208.68 |
| May 04, 2026 | $211.16 |
| May 05, 2026 | $213.46 |
| May 06, 2026 | $214.59 |
| May 07, 2026 | $212.81 |
| May 08, 2026 | $210.60 |
| May 11, 2026 | $209.47 |
| May 12, 2026 | $210.18 |
| May 13, 2026 | $207.97 |
| 4 days before | 1.98% |
| 4 days after | -2.27% |
| On release day | -1.04% |
| Change in period | -0.340% |
Reinsurance Group of America Earnings Call Transcript Summary of Q1 2026
RGA delivered a strong Q1 2026 with broad-based performance across regions and product lines. Adjusted operating pretax income for the quarter was $611 million (approximately $6.97 per share after tax). Key drivers included favorable biometric claims experience (economic claims favorable by $117 million in Q1 and $343 million cumulative since 2023), continued earnings emergence from business written in recent years, solid investment performance, and disciplined capital deployment ($338 million deployed into in-force transactions during the quarter). Regional highlights: Asia Pacific and EMEA showed strong Financial Solutions momentum and transaction activity (notably longevity deals in EMEA and coinsurance in Japan); U.S. individual life and group businesses showed favorable experience and strong underwriting-driven new business flows. Capital and balance sheet: estimated excess capital ended the quarter at $2.4 billion with estimated next-twelve-months deployable capital of $2.9 billion; RGA repurchased $50 million of shares in the quarter (total $175 million since buybacks resumed); management expects to allocate $400 million of excess capital to reduce leverage in 2026 and target returning 20%–30% of after-tax operating earnings to shareholders over the long term. Investment profile: private credit comprises ~9% of the portfolio and remains a measured allocation with most below-investment-grade private assets first-lien senior secured. Assumptions & outlook: management assumes 7% variable investment income for 2026 (below longer-term 10%–12% due to muted real estate sales), views pipeline as healthy, remains selective on transactions, and is confident in meeting intermediate-term financial targets. Notable items and sensitivities: run-rate EPS for Q1 estimated at ~$6.70; deferred favorable economic experience will be recognized over the life of the business (current annualized recognition impact is modest at roughly $20 million/year); management is monitoring GLP-1 developments but has not made material assumption changes; recent regulatory items (UK PRA counterparty charge, NAIC AG55) are not expected to materially impact RGA given business mix and structures. Overall message: disciplined underwriting, diversified global platform, selective capital deployment, and active in-force management underpin confidence in continuing to deliver attractive returns.
Sign In
Buy RGA